MedTrace Logo

Clinical Trials

NCT07220291 | RECRUITING | NA
45 participants

YK Delta Food Box Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2026-05-20
Completion:
2027-09-30
Conditions
  • Food Insecurity
Interventions
  • OTHER
No Results Yet
NCT07217145 | ACTIVE_NOT_RECRUITING | PHASE3
1455 participants

PREVENT HPV -Related Cancers Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2025-10-09
Completion:
2026-07-01
Conditions
  • HPV Vaccination
  • Uptake Vaccination
  • Series Completion
Interventions
  • BEHAVIORAL
No Results Yet
NCT07207135 | COMPLETED | NA
44 participants

Most Effective Knee Joint Angle Pair for Isometric Exercise

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2025-01-15
Completion:
2025-05-12
Conditions
  • Isometric Exercise
  • Exercise Training
  • Musculoskeletal Function
  • Balance, Proprioception, and Functional Performance
  • Healthy Volunteers
Interventions
  • OTHER
No Results Yet
NCT07194850 | RECRUITING | PHASE2/PHASE3
24 participants

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2025-10-20
Completion:
2028-10-31
Conditions
  • Immune Thrombocytopenia (ITP)
  • ITP - Immune Thrombocytopenia
  • ITP
  • Immune Thrombocytopenic Purpura
  • Immune Thrombocytopenic Purpura ( ITP )
  • Idiopathic Thrombocytopenic Purpura
  • Idiopathic Thrombocytopenic Purpura (ITP)
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT07189390 | RECRUITING | PHASE2
360 participants

The Bloom Infant Probiotic (BIP) Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2026-05-25
Completion:
2029-05-31
Conditions
  • Infant, Newborn
  • Immunity
  • Immunisation
  • Antibiotic Treatment
  • Microbiome Dysbiosis
Interventions
  • DRUG
No Results Yet
NCT07137416 | RECRUITING | PHASE1
36 participants

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2026-10-05
Completion:
2028-01-10
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Invasive Breast Carcinoma
  • Locally Advanced Breast Carcinoma
  • Metastatic Breast Carcinoma
  • Metastatic HER2-Low Breast Carcinoma
  • Metastatic HER2-Positive Breast Carcinoma
  • Metastatic Hormone Receptor-Positive Breast Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Triple-Negative Breast Carcinoma
  • Unresectable Breast Carcinoma
  • Unresectable HER2-Low Breast Carcinoma
  • Unresectable HER2-Positive Breast Carcinoma
  • Unresectable Hormone Receptor-Positive Breast Carcinoma
  • Unresectable Malignant Solid Neoplasm
  • Unresectable Triple-Negative Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT07128199 | ACTIVE_NOT_RECRUITING | PHASE3
360 participants

A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2025-12-22
Completion:
2029-10-01
Conditions
  • NSCLC, Stage IB-IIIA
  • Lung Cancer
  • Adjuvant
  • Post-surgical
  • EGFR
  • Exon 20
  • Early Stage Lung Cancer
  • Uncommon EGFR Mutations
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page